Cargando…
Application and Prospects of Molecular Imaging in Immunotherapy
Recently, immunotherapies that target the interactions of programmed cell death 1 (PD-1) with its major ligands, programmed death ligand 1 (PD-L1) and programmed death ligand 2 (PD-L2), have achieved significant success. To date, several immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway...
Autores principales: | Wang, Weiqing, Gao, Zhenhua, Wang, Lu, Li, Jianing, Yu, Jinming, Han, Shumei, Meng, Xue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533904/ https://www.ncbi.nlm.nih.gov/pubmed/33061627 http://dx.doi.org/10.2147/CMAR.S269773 |
Ejemplares similares
-
Immunotherapy for recurrent glioblastoma: practical insights and challenging prospects
por: Wang, Xin, et al.
Publicado: (2021) -
Molecular imaging of tumor-associated macrophages in cancer immunotherapy
por: Li, Xiaoying, et al.
Publicado: (2022) -
Molecular imaging for cancer immunotherapy
por: Lim, E.A., et al.
Publicado: (2020) -
(18)F-RGD PET/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment
por: Liu, Jie, et al.
Publicado: (2021) -
Current applications and future prospects of nanotechnology in cancer immunotherapy
por: Yan, Sen, et al.
Publicado: (2019)